Colgate-Palmolive (NYSE:CL) Shares Sold by Beacon Financial Advisory LLC

Beacon Financial Advisory LLC lowered its stake in shares of Colgate-Palmolive (NYSE:CL) by 3.6% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 11,030 shares of the company’s stock after selling 415 shares during the quarter. Beacon Financial Advisory LLC’s holdings in Colgate-Palmolive were worth $1,145,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors have also modified their holdings of CL. Long Run Wealth Advisors LLC acquired a new stake in shares of Colgate-Palmolive in the 3rd quarter valued at about $207,000. Fiduciary Family Office LLC acquired a new position in shares of Colgate-Palmolive in the 3rd quarter valued at $704,000. Crestwood Advisors Group LLC raised its position in Colgate-Palmolive by 1.2% in the 3rd quarter. Crestwood Advisors Group LLC now owns 34,176 shares of the company’s stock valued at $3,548,000 after purchasing an additional 407 shares during the last quarter. Amalgamated Bank boosted its stake in Colgate-Palmolive by 6.6% during the 3rd quarter. Amalgamated Bank now owns 182,571 shares of the company’s stock worth $18,953,000 after purchasing an additional 11,377 shares during the period. Finally, FSM Wealth Advisors LLC acquired a new position in Colgate-Palmolive in the third quarter valued at $204,000. Hedge funds and other institutional investors own 80.41% of the company’s stock.

Insider Transactions at Colgate-Palmolive

In other news, Director Martina Hundmejean sold 2,313 shares of the company’s stock in a transaction on Friday, August 23rd. The stock was sold at an average price of $103.86, for a total value of $240,228.18. Following the sale, the director now directly owns 11,755 shares in the company, valued at $1,220,874.30. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. In other Colgate-Palmolive news, insider Panagiotis Tsourapas sold 14,794 shares of Colgate-Palmolive stock in a transaction that occurred on Thursday, August 8th. The shares were sold at an average price of $102.94, for a total value of $1,522,894.36. Following the completion of the sale, the insider now directly owns 5,146 shares of the company’s stock, valued at approximately $529,729.24. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Martina Hundmejean sold 2,313 shares of the stock in a transaction on Friday, August 23rd. The stock was sold at an average price of $103.86, for a total value of $240,228.18. Following the transaction, the director now directly owns 11,755 shares in the company, valued at approximately $1,220,874.30. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 0.37% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts recently issued reports on the company. Morgan Stanley raised their price target on Colgate-Palmolive from $103.00 to $111.00 and gave the stock an “overweight” rating in a report on Monday, July 29th. Deutsche Bank Aktiengesellschaft cut Colgate-Palmolive from a “buy” rating to a “hold” rating and upped their price target for the stock from $107.00 to $109.00 in a research note on Monday, September 9th. Evercore ISI boosted their price objective on shares of Colgate-Palmolive from $100.00 to $106.00 and gave the company an “outperform” rating in a research note on Thursday, July 18th. Barclays raised their target price on shares of Colgate-Palmolive from $91.00 to $96.00 and gave the stock an “equal weight” rating in a research note on Monday, July 29th. Finally, UBS Group boosted their price target on shares of Colgate-Palmolive from $119.00 to $122.00 and gave the stock a “buy” rating in a research note on Wednesday, September 4th. One research analyst has rated the stock with a sell rating, nine have issued a hold rating and thirteen have given a buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $105.11.

Colgate-Palmolive Price Performance

Colgate-Palmolive stock opened at $94.26 on Wednesday. The company has a quick ratio of 0.68, a current ratio of 1.04 and a debt-to-equity ratio of 9.46. The firm’s 50-day simple moving average is $101.80 and its 200 day simple moving average is $98.45. Colgate-Palmolive has a 52 week low of $74.67 and a 52 week high of $109.30. The firm has a market capitalization of $77.01 billion, a PE ratio of 27.01, a P/E/G ratio of 3.33 and a beta of 0.42.

Colgate-Palmolive Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, November 15th. Stockholders of record on Friday, October 18th will be paid a dividend of $0.50 per share. The ex-dividend date is Friday, October 18th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.12%. Colgate-Palmolive’s dividend payout ratio (DPR) is 57.31%.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.